Ardea Biosciences, Inc. (NASDAQ: RDEA), headquartered in San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV).

Webcasts
Cowen and Company 30th Annual Health Care Conference Monday, March 8, 2010, 1:00 pm ET Boston, MA
12th Annual BIO CEO & Investor Conference Tuesday, February 9, 2010, 11:00 am ET New York, NY

 

Latest News and Press Releases

To Review All Press Releases click here